Husnu Pullukcu
Overview
Explore the profile of Husnu Pullukcu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
998
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Acet O, Dirik S, Pullukcu H, Tasbakan M, Gokengin D
Curr HIV Res
. 2024 Dec;
22(6):395-401.
PMID: 39629573
Introduction/objective: The SARS-CoV-2 pandemic has led to significant changes in the lives, habits, and frequency of hospital admissions of People Living with HIV (PLWH). However, information is limited on the...
2.
Gul A, Erkunt Alak S, Can H, Karakavuk M, Korukluoglu G, Altas A, et al.
Sci Rep
. 2024 Jun;
14(1):13865.
PMID: 38879684
Severe acute respiratory syndrome coronavirus 2 had devastating consequences for human health. Despite the introduction of several vaccines, COVID-19 continues to pose a serious health risk due to emerging variants...
3.
Baskol Elik D, Yildirim C, Akyol Seyhan D, Erdem H, Zeytinoglu A, Pullukcu H, et al.
Vaccine
. 2024 May;
42(19):3961-3967.
PMID: 38719693
The rates of nasopharyngeal meningococcal carriage in healthcare workers are unknown. Meningococcal vaccine is recommended for risk groups but healthcare workers are not included in risk groups for many countries....
4.
Sanlidag Isbilen G, Durusoy Onmus I, Cankayali I, Demirag K, Uyar M, Cicek C, et al.
New Microbiol
. 2024 May;
47(1):47-51.
PMID: 38700883
One of the drugs that has been suggested for the treatment of SARS-CoV-2 infection is tenofovir disoproxil (TDF). Herein, it was aimed to evaluate the outcomes of TDF receiving COVID-19...
5.
Celen M, Erturk Sengel B, Kaya S, Demirturk N, Azap A, Pullukcu H, et al.
J Infect Dev Ctries
. 2024 Apr;
18(3):441-449.
PMID: 38635621
Introduction: The aim of this national, multicenter, cross-sectional, retrospective chart review study was to determine the proportion of patients in Turkey who received hepatitis C virus (HCV) treatment after receiving...
6.
Karakavuk M, Can H, Celtik A, Karakavuk T, Gul C, Erdem H, et al.
Indian J Med Microbiol
. 2024 Mar;
49:100571.
PMID: 38554777
Purpose: Toxoplasma gondii is an obligate intracellular zoonotic parasite that can infect all warm-blooded animals, including humans. Currently, clinical findings of toxoplasmosis are being related to T. gondii strains such...
7.
Baskol Elik D, Kaya S, Alkan S, Demirdal T, Sener A, Kaya S, et al.
Sci Rep
. 2024 Mar;
14(1):5218.
PMID: 38433274
This multicentre (22 centres in Turkey) retrospective cohort study aimed to assess the clinical outcomes of patients with neutropenic fever and SARS-CoV-2 positivity. Study period was 15 March 2020-15 August...
8.
Ozkaya H, Elazab K, Turan B, Nazli A, Ozturk B, Pullukcu H, et al.
J Acquir Immune Defic Syndr
. 2024 Feb;
96(1):77-84.
PMID: 38346425
Background: Late diagnosis of HIV infection is a major global problem. In Turkiye, only 41%-50% of people living with HIV are diagnosed, suggesting that many opportunities for HIV testing might...
9.
Yaylali E, Erdogan Z, Calisir F, Pullukcu H, Yildirim F, Inan A, et al.
Front Public Health
. 2024 Feb;
12:1224449.
PMID: 38344235
Background: To effectively control the HIV epidemic and meet global targets, policymakers recommend the rapid initiation of antiretroviral therapy (ART). Our study aims to investigate the effect of rapid ART...
10.
Soylu M, Sagiroglu P, Ozarslan M, Acet O, Yuce Z, Izci Cetinkaya F, et al.
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250872
Various clinical outcomes, reinfections, vaccination programs, and antibody responses resulted from the COVID-19 pandemic. This study investigated the time-dependent changes in SARS-CoV-2 antibody responses in infected and/or vaccinated and unvaccinated...